NewsBot
12-18-2007, 03:40 PM
<img alt="" height="1" width="1">
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical ... (http://news.google.com/news/url?sa=T&ct=us/4-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125122494&ei=LTBoR6_ID5O8zATs2MQ5)
CNNMoney.com - 5 hours ago
AZ-104 is a lower dose version of AZ-004, which is being developed to treat acute agitation in patients with schizophrenia or bipolar disorder. ...
More... (http://news.google.com/news/url?sa=T&ct=us/4-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125122494&ei=LTBoR6_ID5O8zATs2MQ5)
Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical ... (http://news.google.com/news/url?sa=T&ct=us/4-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125122494&ei=LTBoR6_ID5O8zATs2MQ5)
CNNMoney.com - 5 hours ago
AZ-104 is a lower dose version of AZ-004, which is being developed to treat acute agitation in patients with schizophrenia or bipolar disorder. ...
More... (http://news.google.com/news/url?sa=T&ct=us/4-0&fd=R&url=http://money.cnn.com/news/newsfeeds/articles/prnewswire/AQTU06818122007-1.htm&cid=1125122494&ei=LTBoR6_ID5O8zATs2MQ5)